Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 4,401–4,408 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Zura Bio Limited Crebankitug (ZB-168) Sjögren-Larssons Syndrome (SLS) Phase 2 Trial Planned Intravenous Genetic Disorder
Zura Bio Limited ZB -168 Ulcerative Colitis Phase 2 Trial Planned Oral Gastroenterology
Zura Bio Limited Crebankitug (ZB-168) Atopic dermatitis Phase 2 Trial Planned Intravenous Immunology
Zymeworks Inc. Ziihera (zanidatamab-hrii) - (HERIZON-GEA-01) First-line HER2-positive gastroesophageal adenocarcinoma (GEA) Phase 3 Data Released Intravenous infusion Oncology
Zymeworks Inc. Ziihera (zanidatamab-hrii) - (HERIZON-GEA-01) First-line HER2-positive gastroesophageal adenocarcinoma (GEA) Phase 3 Data Released Intravenous infusion Oncology
Zymeworks Inc. Zanidatamab (ZW25) - (HERIZON‚ÄëGEA‚Äë01) HER2-positive Gastroesophageal Adenocarcinoma (GEA) Phase 3 Ongoing Intravenous Oncology
Zymeworks Inc. Zanidatamab (ZW25) - (mGEA) HER2-expressing Gastrointestinal Cancers (Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer) Phase 2 Data Released Intravenous Oncology
Zymeworks Inc. Zanidatamab (ZW25) with IBRANCE (palbociclib) and Fulvestrant 3L+ HER2-positive, HR-positive breast cancer Phase 2 Data Released Intravenous Oral Intramuscular Oncology
1…549550551552553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.